Prescribing for Older Adults: Managing Dementia in Aging
This paper examines dementia as a psychiatric disorder disproportionately affecting older adults, with a focus on the role of Psychiatric-Mental Health Nurse Practitioners (PMHNPs) in its management. It reviews the clinical features and types of dementia — including Alzheimer's disease, vascular dementia, and frontal-temporal dementia — and evaluates three treatment approaches: FDA-approved pharmacotherapy (aducanumab), off-label drug use (donepezil and cholinesterase inhibitors), and non-pharmacological interventions such as Cognitive Stimulation Therapy. The paper also assesses the risks and benefits of each approach and outlines relevant clinical practice guidelines for dementia care.
- Introduction: Mental Health and Aging: Psychiatric disorders are more common in older adults
- Understanding Dementia and Its Types: Dementia types, symptoms, and diagnostic overview
- FDA-Approved Treatment: Aducanumab: FDA-approved aducanumab reduces amyloid brain deposits
- Off-Label Drug Use: Cholinesterase Inhibitors: Donepezil used off-label to slow dementia symptoms
- Non-Pharmacological Interventions: Cognitive Stimulation Therapy addresses behavioral symptoms
- Risks, Benefits, and Clinical Practice Guidelines: Risk-benefit analysis and clinical recommendations for dementia
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly organizes three distinct treatment categories — FDA-approved, off-label, and non-pharmacological — allowing direct comparison of approaches for the same condition.
- Grounds clinical recommendations in a specific professional role (PMHNP), giving the analysis a practical, applied perspective rather than a purely academic one.
- Balances pharmacological detail with patient-centered considerations such as caregiver involvement, side-effect counseling, and dignity in care.
Key academic technique demonstrated
The paper uses a comparative framework to evaluate multiple treatment modalities for a single disorder, citing FDA guidance, peer-reviewed journal articles, and clinical databases. This technique — systematically weighing benefits and risks across treatment options — is characteristic of evidence-based clinical writing in nursing and healthcare education.
Structure breakdown
The paper opens with a brief introduction on psychiatric disorders in aging, then defines dementia and its major subtypes. It proceeds through three treatment approaches in sequence, dedicating a short section to each. A combined risks-and-benefits section evaluates both pharmacological options, and a closing clinical guidelines section synthesizes best-practice recommendations for PMHNPs. The structure mirrors a clinical decision-making pathway.
Introduction: Mental Health and Aging
Some psychiatric disorders are more prevalent in older adults than in younger populations, largely due to cerebral-neural degeneration. These disorders are often not recognized in time and are therefore not treated properly, despite their prevalence. Mental disorders in older adults can lead to disability, suicide, or a significantly diminished quality of life. This paper examines one such disorder from the DSM-5 that disproportionately affects older adults: dementia.
Understanding Dementia and Its Types
Dementia is a disorder characterized by the inability to make sound decisions, think clearly, or recall information that was once easy to remember. Many people mistakenly assume that dementia is a normal part of aging, but this is not the case. Early signs include forgetting to eat a meal or how to prepare one, becoming disoriented, and losing familiarity with once-familiar routes. People with dementia may also experience impaired judgment — for example, a farmer may lose the insight to know what to plant in a given season. Dementia has also been associated with hallucinations and loss of balance.
There are many types of dementia, but the most common — accounting for approximately 80% of cases — is Alzheimer's disease. This disease has no cure, though medications that help protect the brain can be administered. Other forms of dementia include mixed dementia, vascular dementia, and frontal-temporal dementia. Dementia can be diagnosed by a healthcare practitioner, who may then prescribe various methods of treatment and strategies to manage the disorder. As a Psychiatric-Mental Health Nurse Practitioner (PMHNP), the recommended course of treatment typically encompasses FDA-approved drugs, off-label (non-FDA-approved) drugs, and non-pharmacological interventions, depending on the stage and presentation of the condition.
Create your account
Always verify citation format against your institution’s current style guide requirements.